Tag Archives: SID

Best Medical Stocks To Watch Right Now

The state of New York just made a huge leap forward with medical marijuana – and the U.S. Department of Veteran Affairs, or VA, is not happy about it.

But it doesn’t matter. The VA stands no chance against medical marijuana’s insane trajectory.

Over the weekend, NY Gov. Andrew Cuomo signed new legislation that allows those in the state with post-traumatic stress disorder (PTSD) to use marijuana to treat symptoms. The bill has been touted as a boon for veterans in particular.

“Our veterans risked their lives in order to defend the ideals and principles that this nation was founded upon, and it is our duty to do everything we can to support them when they return home,” said Cuomo, according to The Associated Press.

New York is the 28th state to legalize medical marijuana for PTSD, and this legislation is in direct opposition to the VA’s negative stance on weed.

Never miss a single marijuana industry update again. To get real-time news sent directly to your inbox,sign up with one click here.

Best Medical Stocks To Watch Right Now: Elbit Systems Ltd.(ESLT)

Advisors’ Opinion:

  • [By Lisa Levin] Companies Reporting Before The Bell
    Booz Allen Hamilton Holding Corporation (NYSE: BAH) is estimated to report quarterly earnings at $0.46 per share on revenue of $1.67 billion.
    Momo Inc. (NASDAQ: MOMO) is projected to report quarterly earnings at $0.5 per share on revenue of $396.17 million.
    Multi-Color Corporation (NASDAQ: LABL) is expected to report quarterly earnings at $1.06 per share on revenue of $424.96 million.
    American Woodmark Corporation (NASDAQ: AMWD) is estimated to report quarterly earnings at $1.15 per share on revenue of $382.4 million.
    The Bank of Nova Scotia (NYSE: BNS) is projected to report quarterly earnings at $1.32 per share on revenue of $5.46 billion.
    Jianpu Technology Inc. (NYSE: JT) is expected to report quarterly loss at $0.04 per share on revenue of $47.51 million.
    Trans World Entertainment Corporation (NASDAQ: TWMC) is estimated to report earnings for its first quarter.
    Advanced Drainage Systems, Inc. (NYSE: WMS) is estimated to report quarterly loss at $0.06 per share on revenue of $249.44 million.
    Quotient Limited (NASDAQ: QTNT) is expected to report quarterly loss at $0.48 per share on revenue of $5.73 million.
    Elbit Systems Ltd. (NASDAQ: ESLT) is projected to report earnings for its first quarter.
    Evogene Ltd. (NASDAQ: EVGN) is expected to report earnings for its first quarter.

     

  • [By Stephan Byrd]

    BidaskClub upgraded shares of Elbit Systems (NASDAQ:ESLT) from a sell rating to a hold rating in a report issued on Wednesday.

    Several other equities research analysts have also weighed in on the company. ValuEngine upgraded Elbit Systems from a hold rating to a buy rating in a report on Thursday, March 1st. TheStreet lowered Elbit Systems from a b rating to a c+ rating in a report on Tuesday, May 29th. Finally, Chardan Capital restated a neutral rating on shares of Elbit Systems in a report on Friday, June 1st. Five investment analysts have rated the stock with a hold rating, Elbit Systems presently has an average rating of Hold and an average price target of $176.00.

  • [By Logan Wallace]

    Shares of Elbit Systems Ltd (NASDAQ:ESLT) have been given an average rating of “Hold” by the five research firms that are covering the company, Marketbeat reports. Four research analysts have rated the stock with a hold recommendation.

  • [By Lisa Levin] Gainers
    TherapeuticsMD, Inc. (NASDAQ: TXMD) rose 7.3 percent to $6.90 in pre-market trading after the company reported the FDA approval of TX-004HR: IMVEXXY (estradiol vaginal inserts) for moderate to severe dyspareunia due to menopause.
    Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) rose 6.1 percent to $10.50 in pre-market trading after falling 1.20 percent on Tuesday
    Movado Group, Inc. (NYSE: MOV) shares rose 5.7 percent to $44.60 in pre-market trading after the company reported better-than-expected Q1 results and raised its guidance.
    salesforce.com, inc. (NYSE: CRM) rose 5.4 percent to $133.67 in pre-market trading after the company reported better-than-expected earnings for its first quarter and raised its forecast for the full year.
    Sirius XM Holdings Inc. (NASDAQ: SIRI) rose 5.3 percent to $7.35 in pre-market trading.
    PagSeguro Digital Ltd. (NYSE: PAGS) rose 5.3 percent to $33.50 in pre-market trading after reporting Q1 results.
    SpartanNash Co (NASDAQ: SPTN) rose 4.9 percent to $19.80 in pre-market trading after the company reported upbeat earnings for its first quarter on Tuesday.
    Groupon, Inc. (NASDAQ: GRPN) rose 4.9 percent to $4.95 in pre-market trading. Dalian Wanda will set up a joint venture with Tencent and Groupon's former local unit, Reuters reported.
    Okta, Inc. (NASDAQ: OKTA) rose 4.4 percent to $56 in pre-market trading after gaining 3.43 percent on Tuesday
    Elbit Systems Ltd. (NASDAQ: ESLT) rose 4.3 percent to $120.92 in pre-market trading after gaining 2.05 percent on Tuesday.
    STMicroelectronics N.V. (NYSE: STM) shares rose 3.7 percent to $23.78 in pre-market trading after falling 4.70 percent on Tuesday.
    EVINE Live Inc (NASDAQ: EVLV) shares rose 2.7 percent to $1.14 in pre-market trading after reporting Q1 results.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Best Medical Stocks To Watch Right Now: National Steel Corporation(SID)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Monday began the week on a solid note for the stock market, with the Dow Jones Industrial Average posting another triple-digit gain as the Nasdaq Compositeclosed at a record high. Despite ongoing nervousness regarding trade, most investors remain convinced that the strong U.S. economy will be able to lead the way forward, pointing to Friday’s employment report as the latest evidence of sustainable momentum. Good news regarding a host of companies both in the U.S. and abroad also helped buoy the market’s mood. Fossil Group (NASDAQ:FOSL), Companhia Siderurgica Nacional (NYSE:SID), and Immunomedics (NASDAQ:IMMU) were among the best performers on the day. Here’s why they did so well.

  • [By Stephan Byrd]

    Companhia Siderurgica Nacional (NYSE:SID)’s share price hit a new 52-week low during trading on Tuesday . The company traded as low as $1.95 and last traded at $1.99, with a volume of 131251 shares. The stock had previously closed at $2.02.

  • [By Rich Smith]

    Confirming that this was not an “oil story” but a “Brazil story,” shares of Brazilian airline Azul SA (NYSE:AZUL) and Brazilian steel company Companhia Siderurgica Nacional (NYSE:SID) likewise declined steeply — closing down 7.2% and 4.8%, respectively. Overall, the Brazilian Ibovespa benchmark stock index closed down 3.7%, after falling as much as 6% in trading earlier in the day.

Best Medical Stocks To Watch Right Now: T-Mobile US, Inc.(TMUS)

Advisors’ Opinion:

  • [By Daniel B. Kline]

    No. 4 wireless carrier Sprint (NYSE:S) lacks a well-established identity. The carrier has sort of piggybacked on the success its rival T-Mobile (NASDAQ:TMUS) has had using lower pricing. The difference, however, is that T-Mobile has a message: It’s not just cheaper, it’s a carrier doing things differently, which has forced the industry to change.

  • [By Daniel B. Kline]

    While Sprint (NYSE:S) has an all-stock deal in place to merge with T-Mobile (NASDAQ:TMUS), there are significant doubts that federal regulators will approve it. If that happens, T-Mobile will go back to its fight against Verizon (NYSE:VZ) and AT&T (NYSE:T), with perhaps some added maverick credibility.

  • [By Adam Levy]

    Telecom investors haven’t seen a reward from the announced T-Mobile (NASDAQ:TMUS) and Sprint (NYSE:S) deal. It still appears that AT&T (NYSE:T) and Verizon (NYSE:VZ) would be two of the biggest beneficiaries if the merger goes through. Nonetheless, both companies’ stock prices are down since T-Mobile and Sprint announced their plans to merge on April 29.

  • [By Adam Levy]

    When T-Mobile (NASDAQ:TMUS) and Sprint (NYSE:S) announced their planned merger, shares of both companies fell along with shares of AT&T and Verizon. The only explanation for the decline in share price across the board is the market’s fears over whether the merger will be approved. The AT&T-Time Warner decision should mitigate those concerns and send stock prices higher across the board.

  • [By Lee Jackson]

    One deal that always looks like a failure, as it has been tried twice before, is a merger between Sprint Corporation (NYSE: S) and T-Mobile USA Inc. (NASDAQ: TMUS). However the approval for AT&T may indicate that some of the consternation over mega-communication companies is changing. That may be especially true as there are multiple bargain wireless subsidiaries like T-Mobile’s MetroPCS and AT&T’s Cricket that supply consumers with choices other than the big-brand companies.

Best Medical Stocks To Watch Right Now: region(XIV)

Advisors’ Opinion:

  • [By Money Morning News Team]

    This led some traders to purchase leveraged ETFs that move inverse to the VIX, like theVelocityShares Daily Inv VIX Short Term(Nasdaq: XIV).

    The VIX is a derivative of the broad S&P 500, and the XIV is a derivative of that derivative.

Best Medical Stocks To Watch Right Now: LivaNova PLC(LIVN)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) jumped 124.8 percent to $243.725 in reaction to an encouraging Phase 2 clinical trial update. The clinical-stage biopharmaceutical company said its liver-directed, thyroid hormone receptor called MGL-3196 showed a statistical significance in the primary endpoint of lowering liver fat at 12 weeks and also 36 weeks.
    Viking Therapeutics, Inc. (NASDAQ: VKTX) gained 63.4 percent to $8.12 after falling 4.42 percent on Wednesday.
    Takung Art Co., Ltd. (NYSE: TKAT) rose 43.3 percent to $2.9094
    vTv Therapeutics Inc. (NASDAQ: VTVT) shares climbed 29.7 percent to $2.16 after the company reported a licensing deal with Newsoara Biopharma to rights for vTv's PDE4 Inhibitor in China and other Pacific Rim territories.
    Akers Biosciences, Inc. (NASDAQ: AKER) gained 26.2 percent to $0.4109. The developer of rapid health information technologies said Wednesday afternoon it was granted a 180-day extension from the Nasdaq Stock Market to meet the requirement of a minimum $1.00 per share closing bid price for 10 straight days.
    Genprex, Inc. (NASDAQ: GNPX) rose 22.2 percent to $11.6254. Genprex reported engagement of WIRB-Copernicus Group to provide clinical trial services to support Oncoprex clinical trial program.
    J.Jill, Inc. (NYSE: JILL) gained 21 percent to $7.506 after the company posted upbeat quarterly earnings.
    Urban One, Inc. (NASDAQ: UONE) gained 19.7 percent to $3.95 after rising 78.38 percent on Wednesday.
    TapImmune, Inc. (NASDAQ: TPIV) shares gained 18.5 percent to $6.03 after climbing 24.15 percent on Wednesday.
    Kirkland's, Inc. (NASDAQ: KIRK) rose 17.3 percent to $12.95 after reporting upbeat Q1 results.
    CymaBay Therapeutics, Inc. (NASDAQ: CBAY) shares gained 15.1 percent to $13.210.
    The Brink's Company (NYSE: BCO) climbed 14.2 percent to $77.875 as the company announced plans to acquire Dunbar Armored for $520 million in cash.
    Keysight Technologies, Inc. (NYSE: KEY
  • [By Max Byerly]

    Get a free copy of the Zacks research report on LivaNova (LIVN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on LivaNova (LIVN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Maxx Chatsko]

    Shares of medical device developer LivaNova (NASDAQ:LIVN) jumped 13% today after the company commented on the U.S. Centers for Medicare & Medicaid Services (CMS) reconsideration of whether or not to cover the technology provider’s Vagus Nerve Stimulation Therapy (VNS Therapy) for treatment-resistant depression (TRD).

  • [By Lisa Levin] Gainers
    Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares surged 144.96 percent to close at $265.61 on Thursday in reaction to an encouraging Phase 2 clinical trial update. The clinical-stage biopharmaceutical company said its liver-directed, thyroid hormone receptor called MGL-3196 showed a statistical significance in the primary endpoint of lowering liver fat at 12 weeks and also 36 weeks.
    Viking Therapeutics, Inc. (NASDAQ: VKTX) shares rose 101.01 percent to close at $9.99 on Thursday after falling 4.42 percent on Wednesday.
    Akers Biosciences, Inc. (NASDAQ: AKER) jumped 45.58 percent to close at $0.474. The developer of rapid health information technologies said Wednesday afternoon it was granted a 180-day extension from the Nasdaq Stock Market to meet the requirement of a minimum $1.00 per share closing bid price for 10 straight days.
    Kitov Pharma Ltd (NASDAQ: KTOV) gained 40.93 percent to close at $3.03 after the FDA approved Kitov's Consensi for the treatment of osteoarthritis pain and hypertension.
    China Customer Relations Centers, Inc. (NASDAQ: CCRC) rose 28.21 percent to close at $19.86.
    J.Jill, Inc. (NYSE: JILL) climbed 26.45 percent to close at $7.84 after the company posted upbeat quarterly earnings.
    Curis, Inc. (NASDAQ: CRIS) shares climbed 21.93 percent to close at $2.78 in reaction to an encouraging FDA update. The biotechnology company that focuses on therapies for the treatment of cancer said the FDA granted a Fast Track designation for fimepinostat (CUDC-907) in patients with relapsed or refractory.
    Boxlight Corporation (NASDAQ: BOXL) gained 21.23 percent to close at $7.48.
    Kirkland's, Inc. (NASDAQ: KIRK) rose 16.21 percent to close at $12.83 after reporting upbeat Q1 results.
    The Brink's Company (NYSE: BCO) jumped 16.2 percent to close at $79.25 as the company announced plans to acquire Dunbar Armored for $520 million in cash.
    Applied Optoelectronics, Inc. (NASDAQ: AAOI) rose 15.14 percent to c
  • [By Joseph Griffin]

    Shares of LivaNova PLC (NASDAQ:LIVN) have received a consensus rating of “Buy” from the eleven research firms that are covering the company, MarketBeat reports. One research analyst has rated the stock with a sell rating, three have given a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company. The average 12 month price target among brokerages that have updated their coverage on the stock in the last year is $88.57.

Best Medical Stocks To Watch Right Now: EnLink Midstream, LLC(ENLC)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    The company took a major step in that direction this week after announcing that it had agreed to sell its stakes in midstream companies EnLink Midstream Partners (NYSE:ENLK) and EnLink Midstream (NYSE:ENLC) for $3.125 billion in cash. The shale driller plans to use that cash to repurchase up to $4 billion of its shares through the end of next year, assuming this transaction closes. These moves could unlock significant shareholder value in the coming year.

  • [By Stephan Byrd]

    EnLink Midstream (NYSE:ENLC) was downgraded by stock analysts at ValuEngine from a “hold” rating to a “sell” rating in a research note issued to investors on Wednesday.

  • [By Matthew DiLallo]

    However, after announcing the sale of its interest in EnLink Midstream Partners (NYSE: ENLK) and EnLink Midstream (NYSE: ENLC) for $3.125 billion in June, it boosted its buyback authorization up to $4 billion. That represents enough cash to retire roughly 20% of its outstanding shares. Devon expects the sale of EnLink to close this July, which will enable it to accelerate the pace of repurchases through the end of 2019.

Top Medical Stocks To Own For 2019

Deutsche Bank set a €70.00 ($83.33) price objective on Stratec Biomedical Systems (ETR:SBS) in a research report released on Wednesday. The firm currently has a neutral rating on the stock.

Separately, Warburg Research set a €62.00 ($73.81) price objective on Stratec Biomedical Systems and gave the stock a neutral rating in a research report on Thursday, April 19th. Five investment analysts have rated the stock with a hold rating and one has given a buy rating to the stock. Stratec Biomedical Systems currently has an average rating of Hold and an average target price of €62.83 ($74.80).

Get Stratec Biomedical Systems alerts:

Shares of SBS stock opened at €74.00 ($88.10) on Wednesday. Stratec Biomedical Systems has a twelve month low of €48.97 ($58.30) and a twelve month high of €75.00 ($89.29).

Top Medical Stocks To Own For 2019: Marathon Petroleum Corporation(MPC)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Strategic Global Advisors LLC raised its stake in shares of Marathon Petroleum Corp (NYSE:MPC) by 38.1% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 16,244 shares of the oil and gas company’s stock after purchasing an additional 4,480 shares during the quarter. Strategic Global Advisors LLC’s holdings in Marathon Petroleum were worth $1,188,000 as of its most recent filing with the Securities and Exchange Commission.

  • [By Tyler Crowe]

    There has been a slew of merger & acquisition activity in the refining industry as of late as companies look to add economy of scale. The rate of consolidation went into warp speed last week when Marathon Petroleum (NYSE:MPC) and Andeavor (NYSE:ANDV) announced their $23 billion merger deal. HollyFrontier isn’t a big fish in this industry, but it does have a reputation for making value-adding acquisitions. So of course, an analyst asked CEO George Damiris on the company’s conference call for his view of the M&A market and what we might expect from HollyFrontier. Here’s his response:

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Thursday was Marathon Petroleum Corp. (NYSE: MPC) which rose about 5% to $80.85. The stocks 52-week range is $49.30 to $83.27. Volume was about 9 million compared to the daily average volume of 5 million.

  • [By Joseph Griffin]

    Traders bought shares of Marathon Petroleum Corp (NYSE:MPC) on weakness during trading on Thursday. $138.21 million flowed into the stock on the tick-up and $102.43 million flowed out of the stock on the tick-down, for a money net flow of $35.78 million into the stock. Of all companies tracked, Marathon Petroleum had the 13th highest net in-flow for the day. Marathon Petroleum traded down ($1.22) for the day and closed at $69.60

  • [By Tyler Crowe]

    It was looking like, for the first time in a while, we were going to be able to look at MPLX’s (NYSE:MPLX) most recent earnings report without having to consider some big transaction down the road that would fundamentally change these numbers and render them useless. Then, just a couple days before earnings were released, MPLX’s parent company,Marathon Petroleum (NYSE:MPC), announced a huge acquisition that could have a profound impact on MPLX down the road.

  • [By Matthew DiLallo]

    MPLX (NYSE:MPLX) has undergone a significant transformation over the past year and a half. The master limited partnership (MLP) completed several transactions with its oil refining parent Marathon Petroleum (NYSE:MPC), which diversified its midstream portfolio and eliminated costly management fees. Those moves position MPLX to continue growing its rock-solid 6.8%-yielding payout at a healthy clip for the next several years, making it an excellent option for income-seeking investors to consider buying.

Top Medical Stocks To Own For 2019: Eagle Bancorp, Inc.(EGBN)

Advisors’ Opinion:

  • [By Ethan Ryder]

    WARNING: “Eagle Bancorp, Inc. (EGBN) Holdings Trimmed by TIAA CREF Investment Management LLC” was first posted by Ticker Report and is the property of of Ticker Report. If you are accessing this news story on another site, it was stolen and republished in violation of United States and international copyright and trademark legislation. The legal version of this news story can be read at https://www.tickerreport.com/banking-finance/3353520/eagle-bancorp-inc-egbn-holdings-trimmed-by-tiaa-cref-investment-management-llc.html.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Eagle Bancorp (EGBN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    SG Americas Securities LLC purchased a new position in Eagle Bancorp, Inc. (NASDAQ:EGBN) during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund purchased 2,686 shares of the financial services provider’s stock, valued at approximately $161,000.

Top Medical Stocks To Own For 2019: (LVMUY)

Advisors’ Opinion:

  • [By ]

    French luxury house LVMH SE (LVMUY) stock surged 3.55% in Paris, changing hands at 278.8 after it reported better-than-expected first quarter sales. Organic revenues rose by 13% in the first three months of the year, driven by its fashion and leather goods division.

  • [By Shane Hupp]

    LVMH Moet Hennessy Louis Vuitton (OTCMKTS:LVMUY) was upgraded by ValuEngine from a “hold” rating to a “buy” rating in a research report issued on Saturday.

  • [By Leo Sun]

    At $126, Tiffany trades at about 27 times this year’s earnings estimate — which is a premium valuation relative to the midpoint of its forecast for 12% growth. LVMH (NASDAQOTH:LVMUY), which owns Tiffany’s rival(and Bogliolo’s former employer) Bulgari, trades at just 25 times this year’s earnings — and analysts expect its EPS to jump 16%. Bulgari, like Tiffany, is pivoting away fromits “old world” charms toward edgier marketing campaigns that target younger shoppers.

  • [By ]

    Two years ago, I discussed LVMH (OTCPK:LVMUY) (OTCPK:LVMHF) in another article here on Seeking Alpha. Although I wasnt too impressed with the companys free cash flow yield, I did agree this company deserved a premium valuation. And on top of that, I was expecting its strong growth results to continue in the years ahead. Were now two years later, and LVMH has delivered on every front. Unfortunately the market caught up on that as well, and LVMHs share price has doubled in just two years. And although the LVMH results justify a good performance of the share price, I do think LVMH is getting a little pricey.

Top Medical Stocks To Own For 2019: Daktronics, Inc.(DAKT)

Advisors’ Opinion:

  • [By Lisa Levin] Companies Reporting Before The Bell
    Dick's Sporting Goods, Inc. (NYSE: DKS) is projected to report its quarterly earnings at $0.45 per share on revenue of $1.89 billion.
    Columbus McKinnon Corporation (NASDAQ: CMCO) is estimated to report its quarterly earnings at $0.5 per share on revenue of $209.35 million.
    Analog Devices, Inc. (NASDAQ: ADI) is expected to report its quarterly earnings at $1.38 per share on revenue of $1.47 billion.
    Michael Kors Holdings Limited (NYSE: KORS) is projected to report its quarterly earnings at $0.59 per share on revenue of $1.15 billion.
    Movado Group, Inc. (NYSE: MOV) is expected to report its quarterly earnings at $0.11 per share on revenue of $109.47 million.
    Chico's FAS, Inc. (NYSE: CHS) is estimated to report its quarterly earnings at $0.26 per share on revenue of $552.31 million.
    DSW Inc. (NYSE: DSW) is projected to report its quarterly earnings at $0.37 per share on revenue of $681.89 million.
    Daktronics, Inc. (NASDAQ: DAKT) is expected to report its quarterly earnings at $0.05 per share on revenue of $147.20 million.
    Destination XL Group, Inc. (NASDAQ: DXLG) is estimated to report a quarterly loss at $0.14 per share on revenue of $107.63 million.
    Bank of Montreal (NYSE: BMO) is expected to report its quarterly earnings at $1.67 per share on revenue of $4.21 billion.
    MakeMyTrip Limited (NASDAQ: MMYT) is projected to report its quarterly loss at $0.39 per share on revenue of $143.03 million.
    EVINE Live Inc. (NASDAQ: EVLV) is expected to report its quarterly loss at $0.02 per share on revenue of $155.98 million.
    RBC Bearings Incorporated (NASDAQ: ROLL) is estimated to report its quarterly earnings at $1.14 per share on revenue of $175.55 million.

     

  • [By Lisa Levin]

    Shares of Daktronics, Inc. (NASDAQ: DAKT) were down 19 percent to $8.17 after reporting weaker-than-expected quarterly results.

    Michael Kors Holdings Limited (NYSE: KORS) was down, falling around 12 percent to $59.86. Michael Kors reported better-than-expected earnings for its fiscal fourth quarter and issued strong first-quarter guidance. However, the company issued cautious profit guidance for the full year.

  • [By Motley Fool Staff]

    Daktronics (NASDAQ:DAKT) Q4 2018 Earnings Conference CallMay. 30, 2018 11:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Max Byerly]

    SG Americas Securities LLC bought a new stake in shares of Daktronics, Inc. (NASDAQ:DAKT) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 12,035 shares of the technology company’s stock, valued at approximately $106,000.

Top Medical Stocks To Own For 2019: First Connecticut Bancorp, Inc.(FBNK)

Advisors’ Opinion:

  • [By Jordan Wathen]

    Shares of First Connecticut Bancorp Inc. (NASDAQ:FBNK) are soaring today, rising by more than 19% as of 11:00 a.m. EDT on news of an acquisition. The parent company ofFarmington Bank will be acquired by People’s United Financial (NASDAQ:PBCT) in an all-stock transaction valued at $544 million.

  • [By Logan Wallace]

    First Connecticut Bancorp (NASDAQ: FBNK) and Berkshire Hills Bancorp (NYSE:BHLB) are both small-cap finance companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, profitability, earnings, institutional ownership, valuation and risk.

  • [By Max Byerly]

    BidaskClub downgraded shares of First Connecticut Bancorp (NASDAQ:FBNK) from a hold rating to a sell rating in a research note issued to investors on Wednesday morning.

  • [By Shane Hupp]

    Wells Fargo & Company MN boosted its holdings in shares of First Connecticut Bancorp Inc (NASDAQ:FBNK) by 8.6% in the first quarter, Holdings Channel reports. The institutional investor owned 148,333 shares of the bank’s stock after purchasing an additional 11,719 shares during the quarter. Wells Fargo & Company MN’s holdings in First Connecticut Bancorp were worth $3,798,000 as of its most recent filing with the Securities and Exchange Commission.

Top Medical Stocks To Own For 2019: National Steel Corporation(SID)

Advisors’ Opinion:

  • [By Rich Smith]

    Brazilian steelmaker Companhia Siderurgica Nacional (NYSE:SID) stock lost 20% of its value in last month’s sell-off, hurt by a shareholder dispute with management and (probably) continued generally negative sentiment regarding South American stocks. This morning, however, shares of CSN are turning around, and trading up 13% as of 12:30 p.m. EDT.

  • [By Dan Caplinger]

    Monday began the week on a solid note for the stock market, with the Dow Jones Industrial Average posting another triple-digit gain as the Nasdaq Compositeclosed at a record high. Despite ongoing nervousness regarding trade, most investors remain convinced that the strong U.S. economy will be able to lead the way forward, pointing to Friday’s employment report as the latest evidence of sustainable momentum. Good news regarding a host of companies both in the U.S. and abroad also helped buoy the market’s mood. Fossil Group (NASDAQ:FOSL), Companhia Siderurgica Nacional (NYSE:SID), and Immunomedics (NASDAQ:IMMU) were among the best performers on the day. Here’s why they did so well.

  • [By Rich Smith]

    Confirming that this was not an “oil story” but a “Brazil story,” shares of Brazilian airline Azul SA (NYSE:AZUL) and Brazilian steel company Companhia Siderurgica Nacional (NYSE:SID) likewise declined steeply — closing down 7.2% and 4.8%, respectively. Overall, the Brazilian Ibovespa benchmark stock index closed down 3.7%, after falling as much as 6% in trading earlier in the day.

5 Things Investors Learned About Fitbit Inc (FIT) Stock in 2017

> Twitter Logo RSS Logo Will Ashworth Popular Posts: 7 Dividend Aristocrats to Buy for Growth, TooWhy Sprint Corp (S) Stock Has the Touch of DeathAlibaba Group Holding Ltd (BABA) vs Mercadolibre Inc (MELI) Recent Posts: 5 Things Investors Learned About Fitbit Inc (FIT) Stock in 2017 7 Non-Tech Stocks Using Tech to Win 7 Dividend Aristocrats to Buy for Growth, Too View All Posts

It hasn’t been a great year for CEO James Park and the rest of the Fitbit Inc (NYSE:FIT) shareholders who’ve seen FIT stock lose almost 18% of its value year to date through Aug. 31 on top of a 75% loss in 2016. Ouch. Ouch. Triple ouch!

5 Things Investors Learned About Fitbit Inc (FIT) Stock in 2017Source: Shutterstock

It’s hard to believe Fitbit finished 2015 with a market cap of $4.9 billion, three-and-a-half times larger than it is today.

There’s no denying what can happen when a company bets on the wrong horse. In the case of Fitbit, it would be its hard press on fitness trackers when the consumer was calling for smart watches that incorporate fitness into the product. 

Hindsight is 20/20, but that’s why CEOs get paid so much — to make the right calls. James Park didn’t, and it’s cost him a lot of money.

I’ve written about Fitbit for InvestorPlace four times this year. I thought I’d go back through those articles to find five kernels of knowledge I’ve gained about the company as we’ve rolled through 2017.

Right or wrong, they’ll determine how FIT stock does the rest of year and into 2018.

Market Share

In early February I wondered if Garmin Ltd. (NASDAQ:GRMN) and Fitbit made a good long/short play because Garmin was wading into the smartwatch industry and Fitbit was losing market share.

At the end of September 2016, Fitbit had 23% market share. By the middle of 2017, according to International Data Corporation, it was down to 12.3%, behind both Apple Inc. (NASDAQ:AAPL) and Xiaomi at 14.6%.

So, in nine months, Fitbit lost almost half its market share. I guess that’s why its stock’s dropped by more than half, as well.

Cash Levels

Also, in my story from early February, I worried about Fitbit’s comfy cash position disappearing — it sat at $672 million at the end of Q3 2016 — but it’s stayed remarkably consistent — it was $675.8 million at the end of June — thanks to significantly cutting its accounts payable outstanding.

While this can’t go on forever, it’s a sign the company is at least trying to cut its costs and keep the coffers flush. On the downside, the revenue reduction year over year means it’s got to do a lot more if it ever wants to make money again.

While revenues in the second quarter were down by 39.8% from a year earlier, operating expenses declined by just 9.6%, and R&D went up. 

There Are Better Alternatives

The one thing I always consider when analyzing a stock is whether there are better alternatives available. Stocks that are making money and don’t carry the same level of risk.

In my article in late February I suggested to readers that Apple would make a better buy than FIT stock; since then, Fitbit stock has been flat while AAPL stock is up 21.0% through August 31.

Sometimes you can have your cake and eat it too.

Cheap Stocks

In April, I did bend a little bit on my opinion of Fitbit, suggesting it made a good buy around $5.40 where it was trading.

“If you’re a speculator, FIT stock is the ideal play at these prices. If you’re a buy-and-hold investor, I believe there’s too much risk associated with owning Fitbit,” I wrote April 17 discussing $5 stocks. “You’re better to own Aegon N.V. (ADR) (NYSE:AEG) if you’re a more conservative investor and if you’re like me and believe in the future for Latin American stocks, Companhia Siderurgica Nacional (ADR) (NYSE:SID) also makes sense, but only as a non-core and tiny piece of your investment portfolio.”

In the four months since FIT, AEG, and SID are up 9.6%, 23.1%, and 14.8% respectively, compared to 6.0% for the SPDR S&P 500 ETF Trust (NYSEARCA:SPY) in the same period.

Clearly, investors felt all three of these stocks had bottomed in price.

Next Page

Chance of a Buyout

I realize the financial media have beaten this subject to death, but that doesn’t make it any less real.

In May, I argued that FIT stock is worth the risk because its balance sheet is still strong, something I referenced earlier, and someone will buy it, more likely a private-equity firm than Garmin or another competitor.

Here’s why. 

Private-equity firms look for one of two things in any acquisition.

First, they look for businesses that they can grow through bolt-on purchases that strengthen the entire operation while allowing for additional organic growth. It’s the multiplier factor if you will.

Secondly, they look for businesses whose cost structure is out of whack and quickly reduced to better reflect a company’s overall revenue. That’s Fitbit to a tee. Its R&D is still way out of line with reasonable growth expectations in the next 12-24 months.

It wouldn’t surprise me if a private equity firm swooped in later this year or early in 2018 and offered to buy Fitbit for $9 a share, which works out to three times its enterprise value.

The big question is whether majority owner and CEO James Park would sell.

Bottom Line on FIT Stock

Unless Fitbit reverses course — it had surprisingly good Q2 2017 numbers — I don’t see its stock retreating from where it currently trades around $6.

What I’ve learned about Fitbit in 2017 is that it’s remarkably resilient; aggressive investors should benefit in the next 6-12 months either through a higher stock price or a buyout.

As of this writing, Will Ashworth did not hold a position in any of the aforementioned securities.

Top 10 Warren Buffett Stocks To Watch For 2018

Berkshire Hathaway Chairman and CEO Warren Buffett

Yesterday, Warren Buffett, the chairman and CEO of Berkshire Hathaway Inc. (NYSE: BRK.A; BRK.B), said he thinks the United States will “work fine” under President Donald Trump.

His reason: America’s got the “secret sauce” – the ability to survive.

“America works,” Buffett told CNBC on Thursday (Jan. 19). “I’ve said this before. It’ll work wonderfully under [former Democratic presidential candidate] Hillary Clinton, and I think it’ll work fine under Donald Trump.”

The billionaire also conceded that he doesn’t think the United States works perfectly, “but you just look at where we go, milestone after milestone. Never bet against America.”

Buffett likewise took the CNBC interview yesterday as an opportunity to reiterate his call to invest now for the long haul…

Top 10 Warren Buffett Stocks To Watch For 2018: VIVUS, Inc.(VVUS)

Advisors’ Opinion:

  • [By Keith Speights]

    Arena is out of the obesity drug business, but what about Orexigen Therapeutics (NASDAQ:OREX) or VIVUS (NASDAQ:VVUS)? The problem is that they’re both too dependent on their respective obesity drugs, Contrave and Qsymia. Neither of the drugs have performed up to expectations.

  • [By Peter Graham]

    A long term chart shows Arena Pharmaceuticals along with its small capobesitytreatmentpeers EnteroMedics Inc (NASDAQ: ETRM), Orexigen Therapeutics, Inc (NASDAQ: OREX) and VIVUS, Inc (NASDAQ: VVUS) all causing severe weight loss for investor portfolios:

Top 10 Warren Buffett Stocks To Watch For 2018: Federated Investors, Inc.(FII)

Advisors’ Opinion:

  • [By Gregg Greenberg]

     Stocks of Federated Investors (FII) fell approximately 9% in 2015, yet Oja expects a big turnaround in 2016, once again due to the prospect of higher rates ahead. 

     

    "The money market fund business, which is unprofitable now, should become more profitable as rates rise because Federated has to reimburse for the servicing fees for these funds," said Oja, who also admires the fund company’s 3.5% dividend yield. 

     

    Oja added that Federated also has a "good core business of equity and fixed-income asset management." 

Top 10 Warren Buffett Stocks To Watch For 2018: Madison Square Garden Inc.(MSG)

Advisors’ Opinion:

  • [By Ian Wyatt, Publisher & Chief Investment Strategist, Wyatt Investment Research]

    Meanwhile, Mark Boyar, of The Boyar Value Fund, recommends another household name: Madison Square Garden (MSG). He thinks the Dolan family could take the company private.

  • [By Monica Gerson]

    Madison Square Garden Co (NYSE: MSG) is estimated to report a quarterly loss at $0.34 per share on revenue of $325.53 million.

    Gogo Inc (NASDAQ: GOGO) is projected to report a quarterly loss at $0.42 per share on revenue of $137.58 million.

Top 10 Warren Buffett Stocks To Watch For 2018: Apogee Enterprises, Inc.(APOG)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    Let me introduce you to Apogee Enterprises (APOG) a company with “yuge” profit potential. Founded in 1949 and headquartered in Minneapolis, Minnesota, APOG designs and develops glass solutions for commercial buildings.

Top 10 Warren Buffett Stocks To Watch For 2018: MGC Diagnostics Corporation(MGCD)

Advisors’ Opinion:

  • [By Monica Gerson]

    MGC Diagnostics Corp (NASDAQ: MGCD) is projected to post earnings for the latest quarter.

    Lands’ End, Inc. (NASDAQ: LE) is estimated to report its quarterly earnings at $0.02 per share on revenue of $293.24 million.

Top 10 Warren Buffett Stocks To Watch For 2018: The Baltic Dry Index Soaring, and Double Crown Resources (DDCC)

Advisors’ Opinion:

  • [By Matthew Briar]

    It’s not only a scenario that bodes well for an up-and-coming company Double Crown Resources Inc. (OTCMKTS:DDCC).

    What if there were a way to remove all the risks and hassle of shipping things like pellets or beans or salt [which are normally delivered in drybulk vessels] but still utilize all the flexibility of intermodal containers… the big box containers that are just at home on the deck of a ship as they are on a flatbed truck as they are on a train car? There is. It’s called Translock2 (Translock Squared), and it’s going to revolutionize the way many material companies deliver their goods. Commodity companies now have an alternative way of shipping their product without constantly handling it – and losing some of it – en route to its final destination.

    The nearby image is a Translock2 container. If it looks vaguely familiar to most, it’s essentially an intermodal container in terms of size and shape, but mechanically serves as delivery and dispensing platform for drybulk goods like rice, fertilizer, etc. The design allows commodities to be moved with all the flexib ility of intermodal transportation, but without any of the headache of aggregating and splitting up those goods en route to their final destination. With Translock2, drybulk purchases are packaged up by the seller at the supply source, and then delivered — just as ordered — all the way to the buyer’s site in the container. No muss, no fuss, and no middleman. It cuts down on expenses, and lost material.

    Its development worth noting, in that it explicitly circumvents the need for drybulk maritime vessels, and turns intermodal container ships into dry cargo vessels.

    The recent unveiling of the Translock 2 containers won’t actually change the amount of drybulk material we as a species consume. But, it will offer dry goods suppliers an easier and often cheaper option to expensive and often difficult dry goods vessel shipping. Remember, the Baltic Dr

  • [By Matthew Briar]

    Don’t let the lethargic Baltic Dry Index fool you — commodities aren’t being used less now than they have been in the past. In fact, most commodities are still seeing increased consumption, including the dry goods the Baltic Dry Index is supposed to gauge transportation for. The Baltic Dry Index remains in a bit of a long-term funk because, as much as the world continues to increase their need for materials like iron ore, grain, and gravel, the world also still has too much capacity to deliver them. See, too many maritime vessels are competing for too few dollars, serving as a drag on the value of the Baltic Dry Index lower. After all, the BDI is mostly just a measure of the daily shipping rates for ocean-born transportation services. It’s not actually a measure of consumption of those materials consumption.

    It’s not only a scenario that doesn’t work against young-and-hungry company Double Crown Resources Inc. (OTCMKTS:DDCC), but it may actually be a scenario that bodes well for it.

    Thought question: What if there was a way to remove all the risks and hassle of shipping goods such as iron ore pellets or beans or salt (commodities that are normally delivered in drybulk vessels) yet still utilize all the flexibility of intermodal containers? There is. It’s called Translock2, or Translock Squared, and it’s going to revolutionize the way many material companies deliver their goods, and the way many drybulk commodity buyers use their material.

    The image nearby is a Translock2 container. It should look vaguely familiar. It’s essentially an intermodal container in terms of size and shape, but mechanically is a delivery and dispensing platform for drybulk goods like sand or rice. The design allows commodities like sand gravel or livestock feed to be moved with all the flexibility of intermodal transportation (on flatbed trucks, by rail, and on the deck of a boat but without any of the logistical headache of aggregating and splitti

  • [By James E. Brumley]

    Despite the lackluster economic headlines and so-so pricing, commodities aren’t being used less and less. Indeed, most commodities continue to see growing consumption. It’s not only a scenario that works in favor of young-and-hungry company Double Crown Resources Inc. (OTCMKTS:DDCC), but what makes Double Crown such a compelling opportunity is that it’s rather insensitive to commodity price fluctuation.

    What’s the biggest risk and hassle of shipping things like pellets or beans or salt? Normally they’re delivered in drybulk vessels, which works, but is rather ineffective. At various points between a supplier and a customer, such goods have to be split up, re-routed, taken off a boat and put on a train (or vice versa). Not only do all the middlemen get expensive, mistakes and spillage cost money.

  • [By Matthew Briar]

    It’s not only a scenario that bodes well for an up-and-coming company Double Crown Resources Inc. (OTCMKTS:DDCC).

    What if there were a way to remove all the risks and hassle of shipping things like pellets or beans or salt [which are normally delivered in drybulk vessels] but still utilize all the flexibility of intermodal containers… the big box containers that are just at home on the deck of a ship as they are on a flatbed truck as they are on a train car? There is. It’s called Translock2 (Translock Squared), and it’s going to revolutionize the way many material companies deliver their goods. Commodity companies now have an alternative way of shipping their product without constantly handling it – and losing some of it – en route to its final destination.

    The nearby image is a Translock2 container. If it looks vaguely familiar to most, it’s essentially an intermodal container in terms of size and shape, but mechanically serves as delivery and dispensing platform for drybulk goods like rice, fertilizer, etc. The design allows commodities to be moved with all the flexib ility of intermodal transportation, but without any of the headache of aggregating and splitting up those goods en route to their final destination. With Translock2, drybulk purchases are packaged up by the seller at the supply source, and then delivered — just as ordered — all the way to the buyer’s site in the container. No muss, no fuss, and no middleman. It cuts down on expenses, and lost material.

    Its development worth noting, in that it explicitly circumvents the need for drybulk maritime vessels, and turns intermodal container ships into dry cargo vessels.

    The recent unveiling of the Translock 2 containers won’t actually change the amount of drybulk material we as a species consume. But, it will offer dry goods suppliers an easier and often cheaper option to expensive and often difficult dry goods vessel shipping. Remember, the Baltic Dr

Top 10 Warren Buffett Stocks To Watch For 2018: Cherokee Inc.(CHKE)

Advisors’ Opinion:

  • [By Lisa Levin]

    Cherokee Inc (NASDAQ: CHKE) shares dropped 32 percent to $5.26 after the company reported a loss for its first quarter on Thursday. The company reported an adjusted loss of $0.07 per share, versus analysts’ estimates for a profit of $0.13 per share.

  • [By Lisa Levin]

    Cherokee Inc (NASDAQ: CHKE) shares dropped 37 percent to $4.85 after the company reported a loss for its first quarter on Thursday. The company reported an adjusted loss of $0.07 per share, versus analysts’ estimates for a profit of $0.13 per share.

Top 10 Warren Buffett Stocks To Watch For 2018: National Steel Corporation(SID)

Advisors’ Opinion:

  • [By Lisa Levin]

    Basic materials shares climbed by 1.52 percent in trading on Friday. Meanwhile, top gainers in the sector included Companhia Siderurgica Nacional (ADR) (NYSE: SID), and Core Molding Technologies, Inc. (NYSE: CMT).

Top 10 Warren Buffett Stocks To Watch For 2018: Catalyst Biosciences, Inc. (CBIO)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Catalyst Biosciences Inc (NASDAQ: CBIO) were down around 27 percent to $5.36. Catalyst Biosciences reported the pricing of $18 million offering of Class A units at $5 per unit

  • [By Ashley Moore]

    Here is a list of the top 10 best small-cap stocks based on price gains per share so far in 2017:

    Company (Ticker)Price per Share% Change AquaBounty Technologies Inc. (Nasdaq: AQB)$14.338,646.99%Rennova Health Inc. (Nasdaq: RNVA)$3.133,333.73%China Gengsheng Minerals Inc. (OTCMKTS: CHGS)$0.021,718.18%Sunshine Heart Inc. (Nasdaq: SSH)$3.851,071.43%CTI BioPharma Corp. (Nasdaq: CTIC)$4.30991.76%Catalyst Biosciences Inc. (Nasdaq: CBIO)$6.22853.85%TearLab Corp. (Nasdaq: TEAR)$4.20707.85%Pulmatrix Inc. (Nasdaq: PULM)$3.86566.10%Real Goods Solar Inc. (Nasdaq: RGSE)$1.43498.75%Calithera Biosciences Inc. (Nasdaq: CALA)$11.70281.54%

Top 10 Warren Buffett Stocks To Watch For 2018: American Financial Group, Inc.(AFG)

Advisors’ Opinion:

  • [By Lee Jackson]

    Aco-chief executive officer of American Financial Group Inc. (NYSE: AFG), Carl Linder, sold a total of 200,000 shares of the property and casualty insurance products provider at prices that ranged from $90.63 to $91.62. The total for the sale was set at $18 million. The shares closed Friday at $91.55, in a52-week range of $65.38 to $92.38. The consensus price target is $95.50.

Hot Heal Care Stocks For 2018

Image via Pexels

JP Livingston is a retiree living in New York City. She lives frugally, and she and her husband and dog share a 325-square-foot apartment. There’s just one key factor that separates her from the rest of the retired population of NYC: She retired at 28.

JP (a pen name she goes under on her blog, TheMoneyHabit.org) graduated Harvard in 2009 and went on to work at an investment firm after graduation, but her investing interest was sparked long before college graduation.

“When I was 12, my dad gave me a copy of Rich Dad, Poor Dad. It ignited my interest in money management (I consider investing just one part of money management),” says JP. “It made me want to start my own business. I also got really interested in real estate investing and would sit at Barnes & Noble reading through everything I could get my hands on.”

Hot Heal Care Stocks For 2018: Isle of Capri Casinos Inc.(ISLE)

Advisors’ Opinion:

  • [By Lisa Levin]

    Isle of Capri Casinos (NASDAQ: ISLE) reported better-than-expected earnings for its fourth quarter on Tuesday.

    The company posted adjusted earnings of $0.62 per share on revenue of $264.9 million. However, analysts were expecting earnings of 0.54 per share on revenue of $266.8 million.

  • [By Lisa Levin]

    Isle of Capri Casinos (NASDAQ: ISLE) shares shot up 30 percent to $22.03. Eldorado Resorts, Inc. (NYSE: ERI) and Isle of Capri Casinos, Inc. struck a merger deal through which the former would buy the latter for $23 a share in cash or 1.638 shares.

  • [By Lee Jackson]

    Isle of Capri Casinos Inc. (NASDAQ: ISLE) had the president of the company selling some stock. Arnold Block parted with 63,648 shares of the gaming company at $26.20 per share. The total for the sale cameto $2 million. He was joined by CEO Eric Hausler and the chief legal officer, Edmund Quatmann, who together sold 163,949 shares forbetween $26.02 and $26.26. Their trades totaled $4 million.The shares closed on Friday at $25.45, so well-timed trades indeed.The 52-week trading range is $13.01 to $26.89, and the consensus price objective is $23.

Hot Heal Care Stocks For 2018: First Harvest Corp., Prior to Reverse Merger with Cannavoices, Inc. (HVST)

Advisors’ Opinion:

  • [By Javier Hasse]

    First Harvest Corp (OTC: HVST), acquired Cannavoices, Inc., a developer of cannabis-focused mobile games and social media platforms.

    "A trend we've seen developing slowly but steadily [is one] wherenew channels are being developed to reach cannabis consumers, primarily due to limits in advertising. There is so much regulation in the space that, in such an entrepreneurial environment where there are really no incumbent leaders, people are trying to be creative and figuring out ways to reach the cannabis consumer, both as an undeserved demographic and, just one that has still got that taboo around it, [leading] to larger players not necessarily getting involved yet." "Basically, they are trying to figure out ways to reach the consumer without direct TV advertising and stuff like that.”

    Related Link: Marijuana Stocks Go On Reversal Mode After 8 Weeks Of Gains: Cannabis Index Down From 52-Week High

Hot Heal Care Stocks For 2018: National Steel Corporation(SID)

Advisors’ Opinion:

  • [By Lisa Levin]

    Basic materials shares climbed by 1.52 percent in trading on Friday. Meanwhile, top gainers in the sector included Companhia Siderurgica Nacional (ADR) (NYSE: SID), and Core Molding Technologies, Inc. (NYSE: CMT).

Hot Heal Care Stocks For 2018: Sibanye Gold Limited(SBGL)

Advisors’ Opinion:

  • [By Lisa Levin] Related NVCN 18 Biggest Mid-Day Losers For Wednesday Legal Overhangs Keep Ladenburg Neutral On Neovasc Despite Positive Tiara Clinical Data Boston Scientific closes Neovasc transaction (Seeking Alpha) Related BSX Watch These 10 Huge Call Purchases In Monday Trade Wonderful Wearables Get Their Own ETF Boston Scientific closes Neovasc transaction (Seeking Alpha) Gainers Neovasc Inc (US) (NASDAQ: NVCN) rose 17.3 percent to $2.65 in pre-market trading after the company reported the close of its $75 million transaction with Boston Scientific Corporation (NYSE: BSX). aTyr Pharma Inc (NASDAQ: LIFE) shares rose 12.3 percent to $4.10 in pre-market trading after the company disclosed 'promising' signals in myopathies with Resolaris in exploratory trials. Globus Maritime Ltd (NASDAQ: GLBS) shares rose 10.1 percent to $6.90 in pre-market trading after climbing 5.03 percent on Monday. Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) shares rose 9.9 percent to $3.00 in pre-market trading. Aurinia Pharmaceuticals appointed Lorin Jeffry “Jeff” Randall to its board and Chairman of the Audit Committee. Ocean Rig UDW Inc. (NASDAQ: ORIG) shares rose 8.7 percent to $2.89 in pre-market trading after surging 19.82 percent on Monday. Full House Resorts, Inc. (NASDAQ: FLL) shares rose 5.1 percent to $2.08 in pre-market trading after declining 1.98 percent on Monday. Seadrill Ltd (NYSE: SDRL) rose 5.1 percent to $4.13 in pre-market trading after surging 3.15 percent on Monday. Noble Corporation (NYSE: NE) rose 5.1 percent to $7.60 in pre-market trading after declining 5.37 percent on Monday. Arbutus Biopharma Corp (NASDAQ: ABUS) rose 5.1 percent to $3.10 in pre-market trading. Arbutus issued additional data from its ARB-1467 Phase II
  • [By Alex McGuire]

    This list ranks gold dividend stocks in the mining sector by dividend yield. And it also includes one of our top gold stock recommendations of 2017…

    Gold Dividend Stock Share Price Year-to-Date Performance Dividend Yield (as of June 30) DRDGOLD Ltd. (NYSE ADR: DRD) $3.19 -39.7% 10.24% Sibanye Gold Ltd. (NYSE ADR: SBGL) $4.70 -33.4% 5.98% Harmony Gold Mining Co. (NYSE ADR: HMY) $1.62 -26.7% 4.56% Gold Fields Limited (NYSE ADR: GFI) $3.41 +13.3% 2.73% Randgold Resources Ltd. (Nasdaq ADR: GOLD) $87.68 +14.9% 1.89% Franco Nevada Corp. (NYSE: FNV) $72.39 +21.1% 1.27% Royal Gold Inc. (Nasdaq: RGLD) $76.85 +21.3% 1.25% Eldorado Gold Corp. (NYSE: EGO) $2.58 -19.9% 1.16% Barrick Gold Corp. (NYSE: ABX) $15.90 -0.5% 0.75% Goldcorp Inc. (NYSE: GG) $13.02 -4.4% 0.62%

    Six of the 10 gold stocks listed above have posted negative returns so far in 2017. The main reason behind their losses has to do with gold price volatility.

  • [By Alex McGuire]

    This list shows the top-performing gold stocks this month, which we’ll be watching in September 2017. While these stocks posted gains in August, we still aren’t recommending them. Instead, we’re going to show you Money Morning Resource Specialist Peter Krauth’s pick for the best gold stock to buy this year…

    Top Gold Stock Share Price August 2017 Gain Sibanye Gold Ltd. (NYSE ADR: SBGL) $6.35 +22.9% Iamgold Corp. (NYSE: IAG) $6.49 +20% Alamos Gold Inc. (NYSE: AGI) $8.17 +15.1% Franco Nevada Corp. (NYSE: FNV) $81.20 +11.6% Hudbay Minerals Inc. (NYSE: HBM) $8.70 +11.5% Gold Fields Ltd. (NYSE ADR: GFI) $4.42 +10.9% Randgold Resources Ltd. (Nasdaq ADR: GOLD) $101.90 +9.6% Harmony Gold Mining Co. (NYSE ADR: HMY) $1.97 +8.8% Agnico Eagle Mines Ltd. (NYSE: AEM) $50.60 +8.4% Yamana Gold Inc. (NYSE: AUY) $2.81 +7.9%

    Life-Changing Profits: This investing strategy has racked up 30 triple-digit wins so far this year – and 46 in the last 12 months. To learn how to get in position for the next one, click here now…

Hot Heal Care Stocks For 2018: Shake Shack, Inc.(SHAK)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Rather than panicking, investors seemed to take the stance as a positive sign that the U.S. economy is ready for at least slightly less accommodative monetary policy going forward. Yet some stocks suffered sharp declines, and Shake Shack (NYSE:SHAK), Fred’s (NASDAQ:FRED), and Seadrill (NYSE:SDRL) were among the worst performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so poorly.

  • [By Peter Graham]

    A long term performance chart shows more recent burger IPOs like small caps Habit Restaurants Inc (NASDAQ: HABT) and Shake Shack Inc (NYSE: SHAK) underperforming while Red Robin Gourmet Burgers andSonic Corporation (NASDAQ: SONC) have remained in positive territory:

  • [By Chris Lange]

    Shake Shack Inc. (NYSE: SHAK) reported fourth quarter financial results after markets closed on Wednesday. The burger joint said that it had $0.09 in earnings per share (EPS) and $73.3 million in revenue. The same period from last year had $0.08 in EPS and $51.06 million in revenue. Thomson Reuters forecast $0.09 in EPS and $70.68 million in revenue.

Hot Heal Care Stocks For 2018: Brooks Automation Inc.(BRKS)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Friday, technology shares fell 3.59 percent. Meanwhile, top losers in the sector included Ultra Clean Holdings Inc (NASDAQ: UCTT), down 5 percent, and Brooks Automation, Inc (NASDAQ: BRKS), down 10 percent.

  • [By Lisa Levin]

    Technology sector was the top gainer in the US market on Monday. Top gainers in the sector included Aviat Networks Inc (NASDAQ: AVNW), Cohu, Inc. (NASDAQ: COHU), and Brooks Automation, Inc (NASDAQ: BRKS).